| Balance Sheets | 2025-10-31 | |||
|---|---|---|---|---|
| Cash | 184 | |||
| Prepaid expenses | 0 | |||
| Total current assets | 184 | |||
| Total assets | 184 | |||
| Accounts payable and accrued expenses | 205,573 | |||
| Due to related parties | 16,602 | |||
| Notes payable | 268,594 | |||
| Total current liabilities | 490,769 | |||
| Total liabilities | 490,769 | |||
| Preferred stock value | 0 | |||
| Preferred stock value-Series APreferred Stock | 0 | |||
| Preferred stock value-Series BPreferred Stock | 5 | |||
| Common shares 750,000,000 authorized shares, par value 0.00001 38,962,050 and 38,962,050 shares issued and outstanding as of october 31, 2025 and july 31, 2025, respectively | 389 | |||
| Additional paid-in capital | 5,195,456 | |||
| Accumulated deficit | -5,686,435 | |||
| Total stockholders' deficit | -490,585 | |||
| Total liabilities and stockholders' deficit | 184 | |||
Quantumzyme Corp. (QTZM)
Quantumzyme Corp. (QTZM)